Itacitinib
INCB 39110-118
Phase 1 small_molecule completed
Quick answer
Itacitinib for Acute Graft-versus-host Disease is a Phase 1 program (small_molecule) at Incyte with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte
- Indication
- Acute Graft-versus-host Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed